Other Names for this Disease
- Heparin-induced thrombocytopenia
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
- ClinicalTrials.gov lists trials that are studying or have studied Heparin-induced thrombocytopenia. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies.
(Hoechst Marion Roussel)
The FDA has approved this product to be used in this manner.
|For anticoagulation in patients with heparin-induced thrombocytopenia and associated thromboembolic disease in order to prevent further thromboembolic complications.|
|More Information about this product||Drug Information Portal|